<DOC>
	<DOCNO>NCT03027674</DOCNO>
	<brief_summary>Objective : To compare efficacy topical 10 % nifedipine versus 5 % sildenafil patient secondary Raynaud 's phenomenon ( RP ) . Methods : A randomized , double-blind , placebo-controlled pilot study take place 10 patient secondary RP . Topical 10 % nifedipine one hand 5 % sildenafil hand apply . The thumbs n't receive cream serve control group . The primary outcome improvement blood flow vessel diameter digital artery measure high frequency color Doppler ultrasound 1 hour treatment .</brief_summary>
	<brief_title>Topical 10 % Nifedipine Versus 5 % Sildenafil Secondary Raynaud</brief_title>
	<detailed_description>Raynaud 's phenomenon ( RP ) exaggerate vascular response characterize least biphasic change ( pallor cyanosis ) skin color digit , induce cold temperature emotional stress , The prevalence vary 3 5 % . In primary RP , evidence secondary cause patient young age onset ( 15 30 year ) , whereas secondary RP , patient older connective tissue disease ( CTD ) , systemic sclerosis ( SSc ) , systemic lupus erythematosus ( SLE ) , dermatomyositis ( DM ) , Sjögren 's syndrome rheumatoid arthritis . In secondary RP endothelial dysfunction intimal fibrosis compromise capillary blood flow . The treatment include maintain warmth whole body , smoke cessation avoid cold exposure , sympathomimetic medication emotional stress . When measure fail , first line drug calcium-channel blocker ( CCBs ) , eg . nifedipine . If CCBs ineffective tolerate , phosphodiesterase type 5 inhibitor ( PDE-5 ) , eg . sildenafil , topical nitrate use alone combination CCBs . Other drug include serotonin reuptake inhibitor , angiotensin receptor blocker prostaglandin . Unfortunately , secondary RP patient CTD often refractory standard therapy , become therapeutic challenge clinician . Based pathophysiology , topical vasodilator may act adjuvant therapy . Several randomized trial demonstrate benefit various form topical nitrate ( eg . nitroglycerin ) . In relation topical agent , solid evidence lacking . Color Doppler ultrasound noninvasive imaging method allow observation good definition skin deep plane , include vascularization real time . The aim study compare efficacy topical 10 % nifedipine versus 5 % sildenafil patient secondary RP use high-frequency color Doppler ultrasound Patients The inclusion criterion consider patient secondary RP associate CTD diagnose follow-up Department Dermatology . Diagnosis CTD make accord ACR classification criterion SSc , Mixed Connective Tissue Disease criterion propose Kasukawa et al , Bohan Peter DM criterion SLICC SLE criterion . The exclusion criterion primary RP patient ; concurrent infection digit ; allergic reaction current use CCB PDE-5 inhibitor ; , , pregnancy , hypo hypertension , history myocardial infarction , stroke , life-threatening arrhythmia . All patient sign write informed consent . The Ethics Committee Pontificia Universidad Católica de Chile approve study protocol . Study design This prospective study conduct August 2016 ( winter ) . After screen , patient treat vasodilator require discontinue least 24 hour randomization . All patient receive immunosuppressive treatment underlying disease . Patient hand ( right versus leave ) randomize treatment topical sildenafil nifedipine cream . The thumbs hand n't receive cream subject serve control . Subjects instruct apply 5 gram 10 % nifedipine cream one hand 5 gram 5 % sildenafil cream opposite hand . Vinyl gloves supply improve absorption cream hand , leave thumb hand glove without cream . Clinical assessment The temperature examination room set 19ºC ( 66ºF ) ≥ 30 min patient underwent high-frequency color Doppler ultrasound examination 1 hour topical treatment . The radiologist extensive experience dermatologic ultrasound , perform sonographic examination . The radiologist blind clinical data study senior dermatologist charge supervision application topical treatment blind color Doppler ultrasound result . The ultrasound equipment Logic E9 XD Clear work high frequency ( upper range 18 MHz ) compact linear probe ( General Electric Health Systems , Waukesha , WI ) . The ultrasound protocol include grey scale , color Doppler spectral curve analysis arterial flow use setting machine study skin superficial structure . The ultrasound device automatically provide value . The primary outcome improvement blood flow digital artery . For Doppler sonography , peak systolic velocity ( PSV , cm/sec ) diameter ( mm ) measure palmar proper digital ( PPD ) artery ( proximal phalanx level ) radial aspect index , middle thumb finger hand . Also , PSV diameter measure dorsal ( PD ) arterial arch proximal nail fold index , middle thumb finger hand . Immediate late adverse effect monitor patient 3 month study . Statistical analysis PSV PPD artery PD arterial arch index middle finger add total PSV . The diameter PPD artery PD arterial arch index middle finger add total diameter . Due low velocity range , value peak systolic velocity cm/sec transform mm/sec . Treatment efficacy assess use difference digital artery blood flow ( total PSV ) diameter ( total diameter ) baseline ( time [ ] = 0 ) 60 minute ( = 60 ) . Difference digital artery blood flow digital artery diameter define ( = 0 ) minus ( = 60 ) ; thus , efficacy treatment reflect negative difference . In case , mean difference le zero indicates study drug cream effective ; mean difference great equal zero indicate study drug cream ineffective . The Wilcoxon signed-rank test pair t-tests use assess change outcomes within group treatment appropriate . All test perform use two-tailed probability p ≤ 0.05 consider statistically significant .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Raynaud Disease</mesh_term>
	<mesh_term>Dermatomyositis</mesh_term>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Clinical diagnosis secondary Raynaud´s phenomenon associate connective tissue disease Primary Raynaud´s phenomenon Current infection digit Known allergic reaction calciumchannel blocker phosphodiesterase type 5 inhibitor Current use calciumchannel blocker phosphodiesterase type 5 inhibitor Pregnancy Hypotension hypertension History myocardial infarction , stroke , lifethreatening arrhythmia .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Raynaud Phenomena</keyword>
	<keyword>System ; Sclerosis</keyword>
	<keyword>Lupus Erythematosus , Systemic</keyword>
	<keyword>Ultrasound</keyword>
	<keyword>sildenafil</keyword>
	<keyword>Nifedipine</keyword>
</DOC>